[
  {
    "ts": null,
    "headline": "AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates",
    "summary": "AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=8f78d7135e2773c17d81092990ca919b835df273c419ba120f471ae5b0959c6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759403401,
      "headline": "AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates",
      "id": 136955609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=8f78d7135e2773c17d81092990ca919b835df273c419ba120f471ae5b0959c6a"
    }
  }
]